During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Ryan Bowen had been planning this baby-piloted battle-mech since before his son was born.
President Barack Obama and First Lady Michelle Obama handed out treats at a White House Halloween party.
Hazmat suits are in rapid production as China beefs up its defences amid fears it will pay a big price for £131bn business ties with Africa.